Isbn: 9786200505552 - analysis of eplarestat-pragabalin by rp-hplc: method development and validation for the simultaneous estimation of eplarestat-pragabalin by rp-hplc (2 Ergebnisse)

ISBN: 
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (2)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

  • Sprache: Englisch

    Verlag: LAP LAMBERT Academic Publishing, 2020

    6200505551 / 9786200505552

    • Softcover

    Anbieter: preigu, Osnabrück, Deutschlandpreigu

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 47,95

    EUR 70,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 5 verfügbar

    Taschenbuch. Zustand: Neu. ANALYSIS OF EPLARESTAT-PRAGABALIN BY RP-HPLC | METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF EPLARESTAT-PRAGABALIN BY RP-HPLC | Ranabir Chanda | Taschenbuch | 100 S. | Englisch | 2020 | LAP LAMBERT Academic Publishing | EAN 9786200505552 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

  • Sprache: Englisch

    Verlag: LAP LAMBERT Academic Publishing, 2020

    6200505551 / 9786200505552

    • Softcover

    Anbieter: Buchpark, Trebbin, DeutschlandBuchpark

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Sehr gut

    EUR 35,11

    EUR 105,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | A basic, Accurate, exact strategy was produced for the concurrent estimation of the Epalrestat and Pregabalin in Tablet dose shape. Chromatogram was go through Std Kromasil 250 x 4.6 mm, 5m. Portable stage containing Buffer: Acetonitrile taken in the proportion 60:40 was pumped through section at a stream rate of 1 ml/min. Cradle utilized as a part of this technique was 0.1% OPA support. Temperature was kept up at 25°C. Advanced wavelength chose was 274.0 nm. Maintenance time of Epalrestat and Pregabalin were observed to be 2.520 min and 3.745 min. %RSD of the Epalrestat and Pregabalin were and observed to be 0.4% and 0.8% separately. %Recovery was acquired as 99.87% and 99.55% for Epalrestat and Pregabalin individually. LOD, LOQ esteems got from relapse conditions of Epalrestat and Pregabalin were 0.153, 0.464 and 0.376, 1.139 separately. Relapse condition of Epalrestat is y = 5471.4x+18850, and y = 4052.9x+4585.1 of Pregabalin. Maintenance times were diminished and run time was diminished, so the strategy created was straightforward and efficient that can be received in customary Quality control test in Industries.…